1-2 of 2
Keywords: Cetuximab
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

What Does the Pipeline Promise about Upcoming Biosimilar Antibodies in Oncology?

Subject Area:
Focus Article , Oncology , Women's and Children's Health
Antonia Busse, Diana Lüftner
Journal: Breast Care
Breast Care (2019) 14 (1): 10–16.
https://doi.org/10.1159/000496834
Published Online: 13 February 2019
... will become much more diversified. Several biosimilars of monoclonal antibodies used in targeted therapy such as cetuximab, pertuzumab, or denosumab are in early development. [email protected] 13 2 2019 © 2019 S. Karger AG, Basel 2019 Copyright / Drug Dosage / Disclaimer...
View articletitled, What Does the Pipeline Promise about Upcoming Biosimilar Antibodies in Oncology?
Open the PDF for What Does the Pipeline Promise about Upcoming Biosimilar Antibodies in Oncology? in another window
Journal Articles

Carcinoma of Unknown Primary – an Orphan Disease?

Subject Area:
Oncology , Women's and Children's Health
Alwin Krämer, Gerdt Hübner, Andreas Schneeweiss, Gunnar Folprecht, Kai Neben
Journal: Breast Care
Breast Care (2008) 3 (3): 164–170.
https://doi.org/10.1159/000136001
Published Online: 19 June 2008
... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. CUP Carcinoma of unknown primary Metastases Cetuximab Breast Care Review Article · Übersichtsarbeit Breast Care 2008;3:164 170 DOI: 10.1159/000136001 Published online...
View articletitled, Carcinoma of Unknown Primary – an Orphan Disease?
Open the PDF for Carcinoma of Unknown Primary – an Orphan Disease? in another window